Compare ABG & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABG | BCPC |
|---|---|---|
| Founded | 1996 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.8B |
| IPO Year | N/A | N/A |
| Metric | ABG | BCPC |
|---|---|---|
| Price | $234.19 | $155.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $261.29 | $176.00 |
| AVG Volume (30 Days) | 180.0K | ★ 238.0K |
| Earning Date | 01-29-2026 | 10-21-2025 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | ★ 61.57 | 22.48 |
| EPS | ★ 28.52 | 4.57 |
| Revenue | ★ $17,827,000,000.00 | $1,013,548,000.00 |
| Revenue This Year | $7.08 | $10.52 |
| Revenue Next Year | $8.49 | $5.69 |
| P/E Ratio | ★ $8.31 | $34.21 |
| Revenue Growth | ★ 8.07 | 7.55 |
| 52 Week Low | $201.68 | $139.17 |
| 52 Week High | $312.56 | $177.40 |
| Indicator | ABG | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 53.51 |
| Support Level | $222.18 | $155.13 |
| Resistance Level | $247.16 | $161.23 |
| Average True Range (ATR) | 7.92 | 4.04 |
| MACD | 0.01 | 0.54 |
| Stochastic Oscillator | 47.23 | 66.69 |
Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 152 new-vehicle stores and 37 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 14 states (mostly Texas, the West, the Mid-Atlantic, and the Southeast). Asbury store brands include McDavid and Park Place in Texas, Koons in the Washington, D.C. area, and the Larry H. Miller brand in the Western US. Asbury generated $17.2 billion of revenue in 2024 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.